For citations:
Kogoniya LM, Markarova EV. Long-term preservation of the effect of immunotherapy with pembrolizumab as a second line treatment for recurrent skin melanoma. Meditsinskiy sovet = Medical Council. 2023;(22):196-200. (In Russ.) https://doi.org/10.21518/ms2023-444